High-Purity, Low-Endotoxin Carbohydrates, Parenteral Grade Excipients and Highly Potent APIs
- Company Details
- Products & Services
- White Papers
- Press Releases
- Regional Offices
- Contact Company
Pfanstiehl Will Attend PepTalk: the Protein Science Week
Pfanstiehl will be attending PepTalk: the Protein Science Week from 19-23 January 2015 in San...
Pfanstiehl Launches cGMP-produced, Parenteral Grade Mannitol for Pharmaceutical Formulations
Pfanstiehl has announced the launch of a new high-purity, low-endotoxin, Mannitol, which is manufactured in the US under strict current good manufacturing practices (cGMP) and ICH Q7...
Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization and Glycoprotein Biosynthesis
Pfanstiehl has announced the launch of cGMP-produced, high purity Mannose (USP/NF, EP), manufactured in the US under ICH Q7 compliant conditions....
Pfanstiehl Gearing Up for Potent API Expansion
Pfanstiehl is aggressively investing in its potent API contract manufacturing capabilities at its US-based cGMP facility located north of Chicago, US....
Pfanstiehl Launches cGMP-produced, Non-Animal-Derived Galactose for Optimizing Cell Culture Media
Pfanstiehl just announced the launch of its new high purity, low endotoxin, non-animal-derived Galactose (USP/NF, EP), manufactured in the US under strict cGMP, ICH Q7-compliant conditions....